Tag Archives: Amber Specialty Pharmacy

Specialty Pharmacy News Roundup: February 2024

The latest specialty pharmacy news and insights. Stay up to date on industry and company trends with Specialty Pharmacy Database and client-specific research

Specialty Pharmacy Limited Distribution Drug Agreements at Year-End 2022

The leading specialty pharmacies were busy signing limited distribution drug agreements at the end of 2022. Here’s a round-up of the activities

Amber Specialty Pharmacy Will Begin Dispensing TZIELD™

Amber Specialty Pharmacy continues to focus on providing personal and individualized care for the most vulnerable patient populations

Amber Specialty Pharmacy Selected by Takeda to Dispense LIVTENCITY™

Amber Specialty Pharmacy announced that it will begin dispensing LIVTENCITY™ (maribavir), the first and only treatment indicated for the treatment of adults and pediatric patients (12 years of age and older and weighing at least 35 kg) with post-transplant CMV infection/disease

PANTHERx and Amber Specialty Pharmacy Selected by ChemoCentryx to Dispense Tavneos

ChemoCentryx selected only Amber Specialty Pharmacy and PANTHERx as its limited distribution network for Tavenos

AstraZeneca’s Saphnelo to Compete with GSK’s Benlysta to Treat Lupus

Saphnelo, while primarily available through the leading specialty drug distributors, is also available through Amber Specialty Pharmacy and US Bioservices